Description
SS-31 10 mg (Elamipretide) Mitochondrial Research Peptide
SS-31 10 mg, also known as Elamipretide, MTP-131 and Bendavia, is a synthetic aromatic-cationic tetrapeptide supplied as a lyophilized powder for advanced mitochondrial research. The peptide is studied for its ability to cross cellular membranes and associate with cardiolipin, a specialized phospholipid concentrated within the inner mitochondrial membrane.
Each vial contains 10 mg of SS-31 research peptide. This focused format is relevant to controlled laboratory studies involving mitochondrial membrane organization, cardiolipin interactions, respiratory-chain function, oxidative signalling and ATP-related cellular bioenergetics.
SS-31 differs from many conventional research peptides because its primary field of investigation is the mitochondrion. Rather than targeting a typical cell-surface receptor, elamipretide research focuses on the structural and functional environment of the inner mitochondrial membrane. This makes SS-31 10 mg a relevant compound for laboratories examining how mitochondrial architecture influences energy production, electron transfer and cellular responses to metabolic or oxidative stress.
What Is SS-31?
SS-31 is the research designation commonly used for elamipretide, a synthetic peptide composed of four amino acids. During its development, the compound has also been identified as MTP-131 and Bendavia. These names refer to the same core research molecule, although finished pharmaceutical and independent research products must not be treated as equivalent without product-specific manufacturing and analytical evidence.
The peptide belongs to a class of aromatic-cationic compounds designed to penetrate cell membranes and concentrate near the inner mitochondrial membrane. Its physicochemical characteristics support interaction with cardiolipin rather than reliance on a conventional membrane receptor. Scientific studies have therefore examined SS-31 within models of mitochondrial structure, oxidative stress, cellular respiration and tissue bioenergetics .
The 10 mg SS-31 vial states the total amount of lyophilized research material in the container. It does not define an experimental concentration or replicate the composition of an authorized pharmaceutical formulation.
Cardiolipin Research
Cardiolipin is a distinctive phospholipid found mainly in the inner mitochondrial membrane. It contributes to the organization of mitochondrial cristae and supports the structural environment in which respiratory-chain complexes operate. Changes in cardiolipin composition, oxidation or organization may affect mitochondrial performance, making it an important target in bioenergetics research.
Elamipretide is studied for reversible association with cardiolipin. Researchers examine whether this interaction can influence membrane organization, preserve the local environment of respiratory proteins and modify mitochondrial responses under experimental stress.
Because cardiolipin is closely linked with inner-membrane structure, SS-31 research often considers both molecular and functional outcomes. These may include membrane integrity, cristae architecture, respiratory-chain organization, electron-transfer efficiency and biochemical indicators of oxidative damage.
The association between SS-31 and cardiolipin is a central part of the compound’s research identity. Accurate SEO descriptions should therefore use terms such as cardiolipin research peptide, mitochondrial membrane peptide and elamipretide research compound without implying guaranteed therapeutic outcomes.
Inner Mitochondrial Membrane Organization
The inner mitochondrial membrane contains the protein complexes responsible for oxidative phosphorylation. Its highly folded cristae structure increases the membrane area available for respiratory activity and helps organize the molecular machinery involved in cellular energy production.
SS-31 is investigated for its relationship with this membrane environment. By associating with cardiolipin, the peptide may influence how membrane lipids and respiratory proteins are arranged under experimental conditions. Laboratory models can examine whether these interactions affect mitochondrial structure, stability or adaptation during cellular stress.
Research in this area may use biochemical assays, microscopy, membrane-potential measurements, oxygen-consumption analysis and other validated methods. Observed effects depend on the experimental model, material quality, concentration and analytical design, so findings should be interpreted within the limits of each study.
Respiratory-Chain and Electron-Transport Research
The mitochondrial respiratory chain transfers electrons through a series of protein complexes embedded in the inner membrane. This process creates the electrochemical gradient used for ATP synthesis. Inefficient electron transfer can contribute to the generation of reactive oxygen species and altered cellular energy balance.
SS-31 research examines whether cardiolipin-associated membrane effects influence the organization or performance of respiratory-chain complexes. The peptide is therefore relevant to experimental work involving electron transport, oxygen consumption, mitochondrial efficiency and stress-related changes in cellular respiration.
These research areas should not be reduced to a single claim about “boosting energy.” Cellular bioenergetics involves multiple interacting pathways, and laboratory results can vary significantly between isolated mitochondria, cultured cells, animal models and clinical studies. A scientifically accurate product description focuses on the mechanisms under investigation rather than promising a predefined outcome.
ATP and Cellular Bioenergetics
Adenosine triphosphate (ATP) is the primary energy-carrying molecule used by cells. Mitochondrial ATP production depends on coordinated electron transport, membrane potential and ATP synthase activity. Disruption at any point in this system can change the energy available for cellular processes.
SS-31 is studied within models that measure ATP-related bioenergetics, mitochondrial respiration and tissue performance. Researchers may compare treated and untreated experimental groups to examine changes in energy production, respiratory efficiency or stress response.
The compound’s relevance to ATP research is indirect and mechanistic: it is investigated through its association with the mitochondrial membrane environment rather than presented as a source of cellular energy. This distinction helps maintain accurate scientific language and avoids oversimplified claims.
Oxidative-Stress Research
Mitochondria are both producers and targets of reactive oxygen species. Under normal conditions, oxidative reactions participate in cellular signalling, while excessive or poorly controlled oxidative stress can affect lipids, proteins and mitochondrial DNA.
Cardiolipin is particularly relevant because oxidative modification of this phospholipid may influence membrane organization and respiratory function. SS-31 research includes experimental assessment of reactive oxygen species, oxidative damage markers, membrane potential and mitochondrial resilience under defined stress conditions.
Results involving oxidative pathways should be interpreted carefully. Changes in a laboratory biomarker do not automatically establish broader biological or clinical effects. Appropriate controls, validated assays and precise material characterization are necessary for meaningful analysis.
SS-31 and Mitochondrial Research Models
SS-31 has been evaluated across preclinical and clinical research programmes involving mitochondrial function. Studies have examined exercise-related endpoints, primary mitochondrial myopathy, Barth syndrome and other conditions associated with altered mitochondrial biology . Results have varied according to the population, endpoint and study design.
The large MMPOWER-3 study in primary mitochondrial myopathy did not meet its two primary efficacy endpoints, demonstrating why results should not be generalized across different mitochondrial disorders or experimental models . Separate elamipretide research in Barth syndrome contributed to a narrowly defined product authorization in the United States, but that authorization applies to a specific regulated medicine and indication rather than to unrelated research vials.
For laboratory use, SS-31 remains valuable as a research compound for investigating mitochondrial membranes, cardiolipin biology and cellular energetics. Its scientific relevance does not depend on presenting every study as positive; transparent interpretation of mixed findings supports more credible content and better research decisions.
SS-31 10 mg Product Specifications
Compound name: SS-31
Generic research name: Elamipretide
Development names: MTP-131 and Bendavia
Vial content: 10 mg
Peptide class: Aromatic-cationic tetrapeptide
Sequence length: Four amino acids
Physical form: Lyophilized powder
Primary research environment: Inner mitochondrial membrane
Key research association: Cardiolipin
Research areas: Membrane organization, respiratory-chain function, oxidative signalling and cellular bioenergetics
Purity: Refer to the batch-specific Certificate of Analysis
Lyophilized SS-31 10 mg Format
SS-31 10 mg is supplied in lyophilized form to support controlled storage, handling and inventory management within a research environment. The dry material should remain securely sealed and clearly identified with the compound name, stated vial content and batch information.
Lyophilized appearance alone cannot verify peptide identity, quantity, purity, sterility or stability. Researchers should review the matching Certificate of Analysis and any available batch documentation before beginning analytical work.
Product documentation should identify SS-31 or elamipretide, the 10 mg stated content, the batch or sample number, the analytical method, the test date and the reported result. Claims concerning purity or independent testing should only be made when they are supported by evidence for the exact batch supplied.
Research Applications
SS-31 10 mg may be relevant to qualified studies involving cardiolipin binding, inner mitochondrial membrane organization, mitochondrial cristae, respiratory-chain complexes, electron transport, membrane potential, ATP-related bioenergetics and oxidative-stress pathways.
The compound can also support comparative research examining mitochondrial performance under baseline and stress conditions. Depending on the model, investigators may evaluate oxygen consumption, redox markers, membrane structure, cellular viability, energy production or tissue-specific mitochondrial responses.
The responsible researcher should determine whether the material is suitable for the intended experiment. Experimental concentrations, preparation methods, controls and analytical procedures should be established under validated institutional protocols rather than inferred from the total vial content.
Quality and Batch Traceability
Reproducible mitochondrial research requires accurate material identification and reliable batch traceability. Before use, verify that the vial label and supporting documents consistently identify SS-31, Elamipretide, the 10 mg total content and the relevant batch number.
Specifications may vary between suppliers, formulations and production lots. Results reported for pharmaceutical-grade material or another research batch cannot automatically be transferred to this product. Independent analytical confirmation may be appropriate when identity or quantitative precision is critical to the study.
Store the unopened vial under the conditions stated in the accompanying product and batch documentation. Protect the material from contamination, moisture, excessive heat and direct light. Maintain clear inventory, handling and disposal records throughout the research process.
Evidence and Interpretation
SS-31 has a substantial research history, but findings differ across models and clinical programmes. Evidence concerning cardiolipin association and mitochondrial membrane biology provides a strong mechanistic basis for laboratory investigation, while study outcomes in specific conditions should be interpreted individually.
A product description should not imply that an SS-31 10 mg research vial is equivalent to an authorized medicine or that findings from a particular study establish universal effects. Accurate positioning should focus on compound identity, mitochondrial research relevance, documented specifications and the limits of the available evidence.
For laboratory and animal research only. Not intended for human use.
Scientific References
[1] Karaa et al. — Elamipretide dose-escalation research in primary mitochondrial myopathy
[2] MMPOWER-2 crossover study of elamipretide
[3] MMPOWER-3 phase 3 study in primary mitochondrial myopathy
[4] Elamipretide research in Barth syndrome